Although several studies have pointed to a correlation between elevated serum IL-6 levels and the development of respiratory failure in patients with COVID-19 [35–37], the lack of routine availability of this measure in many hospitals led us to use the SCOPE without taking IL6 levels into account -called a simplified SCOPE- and to assess its behavior in our study. This evidence concerns the gene IL6 and respiratory failure.